Surfactant and perfluorocarbon aerosolization by means of inhalation catheters for the treatment of respiratory distress syndrome: An in vitro study

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 24, Issue 2, 2011, Pages 81-87

  Murgia, Xabier ^a   Gastiasoro, Elena ^a   Mielgo, Victoria ^a   Alvarez Diaz, Francisco ^a   Lafuente, Hector ^a   Valls I Soler, Adolf ^b   Gomez Solaetxe, Miguel Angel ^b   Larrabe, Juan Luis ^b   Rey Santano, Carmen ^a  

^a HOSPITAL DE CRUCES   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

aerosol; inhalation catheter; kinematic viscosity; perfluorocarbon; Respiratory Distress Syndrome; surfactant

Indexed keywords

FLUORINERT; FLUOROCARBON; FLUOROCARBON FC 75; PERFLUORODECALIN; PERFLUOROOCTYLBROMYDE; PORACTANT; SURFACTANT; UNCLASSIFIED DRUG;

AEROSOL; ARTICLE; CATHETER; DRUG DELIVERY SYSTEM; FLOW RATE; IN VITRO STUDY; INHALATION CATHETER; NEBULIZER; PHYSICAL CHEMISTRY; RESPIRATORY DISTRESS SYNDROME; VISCOSITY;

ADMINISTRATION, INHALATION; AEROSOLS; ANALYSIS OF VARIANCE; BIOLOGICAL PRODUCTS; CATHETERS; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; FLUOROCARBONS; KINETICS; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; PHOSPHOLIPIDS; PULMONARY SURFACTANTS; RESPIRATION DISORDERS; RHEOLOGY; VISCOSITY;

EID: 79953879012     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2010.0831     Document Type: Article

References (30)

1. Kaiser JR, Gauss CH, and Williams DK: Surfactant admin-istration acutely affects cerebral and systemic hemodynam-ics and gas exchange in very low birth weight infants. J Pediatr. 2004;144:809-814. (Pubitemid 38858101)
2. Cowan F, Whitelaw A, Wertheim D, and Silverman M: Cerebral blood flow velocity changes after rapid adminis-tration of surfactant. Arch Dis Child. 1991;66:1105-1109.
3. Davies MW, Dunster KR, Wilson K, and Colditz PB: Per-fluorocarbon dosing when starting partial liquid ventilation: haemodynamics and cerebral blood flow in preterm lambs. Neonatology. 2010;97:144-153.
4. Griese M, Bufler P, Teller J, and Reinhardt D: Nebulization of a bovine surfactant in cystic fibrosis: a pilot study. Eur Respir J. 1997;10:1984-1994.
5. Babu KS, Woodcock DA, Smith SE, Stainiforth JN, Holgate ST, and Conway JH: Inhaled synthetic surfactant abolishes the early allergen-induced response in asthma. Eur Respir J. 2003;21:1046-1049. (Pubitemid 36675624)
6. Kelly KP, Stenson BJ, and Drummond GB: Randomized comparison of partial liquid ventilation, nebulised per-fluorocarbon, porcine surfactant, artificial surfactant, and combined treatments on oxygenation, lung mechanics, and survival in rabbits after saline lung lavage. Intensive Care Med. 2000;26:1523-1530.
7. Lutz C, Carney D, Finck C, Picone A, Gatto LA, Paskanik A, Langenback E, and Nieman G: Aerosolized surfactant im-proves pulmonary function in endotoxin-induced lung in-jury. Am J Respir Crit Care Med. 1998;158:840-845. (Pubitemid 28449450)
8. von der Hardt K, Schoof E, Kandler MA, Dötsch J, and Rascher W: Aerosolized perfluorocarbon suppresses early pulmonary inflammatory response in a surfactant-depleted piglet model. Pediatr Res. 2002;51:177-182. (Pubitemid 34101331)
9. Kandler MA, von der Hardt K, Schoof E, Dötsch J, and Rascher W: Persistent improvement of gas exchange and lung mechanics by aerosolized perfluorocarbon. Am J Respir Crit Care Med. 2001;164:31-35. (Pubitemid 33151294)
10. Schermuly R, Schmehl T, Günther A, Grimminger F, Seeger W, and Walmrath D: Ultrasonic nebulization for efficient delivery of surfactant in a model of acute lung injury. Impact of gas exchange. Am J Respir Crit Care Med. 1997;156:445-453. (Pubitemid 27351977)
11. Berggren E, Liljedahl M, Winbladh B, Andreasson B, Cur-stedt T, Robertson B, and Schollin J: Pilot study of nebulized surfactant therapy for neonatal respiratory distress syn-drome. Acta Paediatr. 2000;89,460-464. (Pubitemid 30636828)
12. Dijk PH, Heikamp A, and Bambang Oetomo S: Surfactant nebulisation prevents the adverse effects of surfactant ther-apy on blood pressure and cerebral blood flow in rabbits with severe respiratory failure. Intens Care Med. 1997;23:1077-1081. (Pubitemid 27489925)
13. Rüdiger M, Gregor T, Burkhardt W, Proquitté H, Wauer RR, and Schmalisch G: Perfluorocarbon species and nebulizer type influence aerosolization rate and particle size of per-fluorocarbon aerosol. J Crit Care. 2004;19:42-47 (Pubitemid 38525975)
14. Kaisers U, Kelly KP, and Busch T: Liquid ventilation. Br J Anaesth. 2003;91:143-151. (Pubitemid 36857323)
15. Guo ZL, Lu GP, Ren T, Zheng YH, Gong JY, Yu J, and Liang YJ: Partial liquid ventilation confers protection againts acute lung injury induced by endotoxin in juvenile piglets. Respir Physiol Neurobiol. 2009;167:221-226.
16. Gastiasoro Cuesta E, Alvarez D́iaz FJ, Arnaiz Renedo A, Fernández Ruanova B, Lopez-Heredia J, Roman Etxebarria L, Alfonso Sánchez LF, and Valls i Soler A: The cardiovascular effects of partial liquid ventilation in newborn lambs after meconium aspiration Pediatr Crit Care Med. 2001;2:334-339.
17. Overbeck MC, Pranikoff T, Yadao CM, and Hirschl RB: Ef-ficacy of perfluorocarbon partial liquid ventilation on lung injury in a model of acute respiratory failure. Crit Care Med. 1996;24:1208-1214. (Pubitemid 26249375)
18. Hirschl RB, Parent A, Tooley R, McCracken M, Johnson K, Shaffer TH, Wolfson MR, and Bartlett RH: Liquid ventila-tion improves pulmonary function, gas exchange and lung injury in a model of respiratory failure. Ann Surg. 1995; 221:79-88.
19. Quintel M, Heine M, Hirschl RB, Tillmanns R, and Wes-sendorf V: Effects of partial liquid ventilation on lung injury in a model of acute respiratory failure: a histologic and morphometric analysis. Crit Care Med. 1998;26:833-843. (Pubitemid 28211393)
20. Barrington KJ, Singh AJ, Etches PC, and Finer NN: Partial liquid ventilation with and without inhaled nitric oxide in a newborn piglet model of meconium aspiration. Am J Respir Crit Care Med. 1999;160:1922-1927. (Pubitemid 30004697)
21. Kradjan WA, and Lakshminarayan S: Efficiency of air compressor driven nebulizers. Chest. 1985;87:12-16.
22. von der Hardt K, Kandler MA, Brenn G, Scheuerer K, Schoof E, Dötsch J, and Rascher W: Comparison of aerosol therapy with different perfluorocarbons in surfactant-depleted ani-mals. Crit Care Med. 2004;32:1200-1206. (Pubitemid 38620991)
23. Hess D, Williams P, Pooler S, and Kacmarek RM: Medica-tion nebulizer performance. Effects of diluent volume, neb-ulizer flow, and nebulizer brand. Chest. 1996;110:498-505 (Pubitemid 26269284)
24. Gregor T, Schmalisch G, Burkhardt W, Proquitté H, Wauer RR, and Rüdiger M: Aerosolization of perfluorocarbons during mechanical ventilation: an in vitro study. Intens Care Med. 2003;29:1354-1360. (Pubitemid 37041165)
25. Bleyl JU, Ragaller M, Tschö U, Regner M, Kanzow M, Hü-bler M, Rasche S, and Alberecht M: Vaporized per-fluorocarbon improves oxygenation and pulmonary function in an ovine model of acute respiratory distress syndrome. Anesthesiology. 1999;91:461-469. (Pubitemid 29365030)
26. Kemming GI, Flondor M, Hanser A, Pallivathukal S, Holt-mannspoetter M, Kneisel FF, Reuter DA, Kisch-Vedel H, and Zwissler B: Effects of perfluorohexan vapor on gas exchange, respiratory mechanics, and lung histology in pigs with injury after endotoxin infusion. Anesthesiology. 2005;103:461-469.
27. Spieth PM, Knels L, Kasper M, Domingues Quelhas A, Wiedemann B, Lupp A, Hübler M, Neto AG, Koch T, and Gama de Abreu M: Effects of vaporized perfluorohexane and partial liquid ventilation on regional distribution of al-veolar damage in experimental lung injury. Intenssive Care Med. 2007;33:308-314. (Pubitemid 46221237)
28. O'Callaghan C, and Barry PW: The science of nebulised drug delivery. Thorax. 1997;52:S31-S44. (Pubitemid 27239451)
29. Finlay JB, Mitchell J, Baran G, and Pevler J: Delivery of medication as large particles at the carina of an in vitro lung model is effective using a nebulizing catheter. Proc Conf Drug Deliv Lungs. 2005;16,34-37.
30. Hess DR: Nebulizers: principles and performance. Respir Care. 2000;45:609-622. (Pubitemid 30484801)